In vitro immunodiagnostic assays for bovine tuberculosis

P R Wood1, J S Rothel

  • 1CSIRO, Division of Animal Health, Parkville, Vic, Australia.

Insights

The bovine interferon gamma (IFN-gamma) assay offers a more sensitive diagnostic tool for bovine tuberculosis than traditional skin tests. Comparing responses to bovine and avian PPD antigens minimizes false positives in cattle.

Area of Science:

  • Veterinary Immunology
  • Infectious Disease Diagnostics
  • Mycobacterial Research

Background:

  • Bovine tuberculosis (TB) diagnosis relies on cellular immune responses to Mycobacterium bovis (M. bovis).
  • Current serological tests for bovine TB exhibit low sensitivity, necessitating complementary diagnostic approaches.
  • Cellular assays, like the intradermal tuberculin test, are standard but have limitations.

Purpose of the Study:

  • To evaluate the diagnostic performance of a novel bovine interferon gamma (IFN-gamma) assay for bovine TB.
  • To assess the sensitivity and specificity of the IFN-gamma assay compared to existing diagnostic methods.
  • To address challenges of cross-reactivity in TB diagnostics through comparative antigen testing.

Main Methods:

  • A whole blood in vitro assay measuring IFN-gamma production in cattle.
  • Field trials in Australia comparing the IFN-gamma assay with the intradermal tuberculin test.
  • Utilized a comparative assay design comparing bovine PPD and avian PPD antigen responses.

Main Results:

  • The bovine IFN-gamma assay demonstrated significantly higher sensitivity than the intradermal tuberculin test in field trials.
  • A comparative assay using bovine PPD and avian PPD effectively mitigated false-positive reactions.
  • Identified M. bovis specific proteins, but their diagnostic utility is limited by immune response diversity.

Conclusions:

  • The bovine IFN-gamma assay is a promising, sensitive diagnostic tool for bovine tuberculosis.
  • Comparative IFN-gamma testing enhances specificity by controlling for cross-reactivity.
  • Further research into host-pathogen interactions is needed to overcome genetic diversity challenges in diagnostics.